Author(s): Helm CW
Abstract Share this page
Abstract Epithelial ovarian cancer is a peritoneal surface malignancy that most often presents with spread of disease within the peritoneal cavity. Overall 5-year survival is around 50\% and progress in improving outcomes is slow. Among other areas of research, hyperthermic intraperitoneal chemotherapy (HIPEC) provides a promising option. This article reviews the current status of treatment of epithelial ovarian cancer, experience with HIPEC to date, and future directions. Copyright © 2012 Elsevier Inc. All rights reserved.
This article was published in Surg Oncol Clin N Am
and referenced in Journal of Molecular and Genetic Medicine